”To date, the authorised mAb products that target SARS-CoV-2 are less than perfect”
Janice M Reichert, Ph.D, is Executive Director at The Antibody Society — an international non-profit association supporting antibody-related research and development. She is also the founder and Editor-in-Chief of mAbs, a peer-reviewed, PubMed-indexed biomedical journal that focuses on topics relevant to antibody research and development, and co-editor of Handbook of Therapeutic Antibodies.